calcium glycerophosphate / monofluorophosphate / pyridoxine Toothpaste
- RxCUI
- 1046421
- RxNorm name
- calcium glycerophosphate / monofluorophosphate / pyridoxine Toothpaste
- Term type
- SCDF
- Status
- Active
- Updated
- 2026-11-06 11:35:58
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 122010
- Active start
- 122010
- Multiple ingredient
- YES
- Branded
- NO
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Toothpaste | 10652 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| calcium glycerophosphate | 1909 |
| monofluorophosphate | 52885 |
| pyridoxine | 684879 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| RXNAV_STR | calcium glycerophosphate / monofluorophosphate / pyridoxine Toothpaste | 1 | NAMES |
| RxNorm Name | calcium glycerophosphate / monofluorophosphate / pyridoxine Toothpaste | 1 | NAMES |
| TTY | SCDF | 1 | ATTRIBUTES |
| RxCUI | 1046421 | 1 | CODES |
UNII Substances#
No records found.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
No records found.
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | A01AA | Caries prophylactic agents | ATC1-4 | sodium monofluorophosphate | |
| ATC | A12CD | Fluoride | ATC1-4 | sodium monofluorophosphate | |
| ATC | A11HA | Other plain vitamin preparations | ATC1-4 | pyridoxine | |
| FDASPL | D025101 | Vitamin B 6 | CHEM | has_chemical_structure | pyridoxine |
| FDASPL | N0000192800 | Vitamin B6 Analog | EPC | has_epc | pyridoxine |
| MEDRT | D005459 | Fluorides | CHEM | has_ingredient | monofluorophosphate |
| MEDRT | D005459 | Fluorides | CHEM | has_ingredient | sodium monofluorophosphate |
| MEDRT | D005994 | Glycerophosphates | CHEM | has_ingredient | calcium glycerophosphate |
| MEDRT | D011736 | Pyridoxine | CHEM | has_ingredient | pyridoxine |
| MEDRT | D011736 | Pyridoxine | CHEM | has_ingredient | pyridoxine hydrochloride |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | calcium glycerophosphate |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | pyridoxine hydrochloride |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | pyridoxine |
| MEDRT | D064420 | Drug-Related Side Effects and Adverse Reactions | DISEASE | may_prevent | pyridoxine |
| MEDRT | D064420 | Drug-Related Side Effects and Adverse Reactions | DISEASE | may_treat | pyridoxine |
| MEDRT | D064420 | Drug-Related Side Effects and Adverse Reactions | DISEASE | may_prevent | pyridoxine hydrochloride |
| MEDRT | D064420 | Drug-Related Side Effects and Adverse Reactions | DISEASE | may_treat | pyridoxine hydrochloride |
| MEDRT | D004942 | Esophagitis, Peptic | DISEASE | may_treat | calcium glycerophosphate |
| MEDRT | D006934 | Hypercalcemia | DISEASE | ci_with | calcium glycerophosphate |
| MEDRT | D006996 | Hypocalcemia | DISEASE | may_treat | calcium glycerophosphate |
| MEDRT | D017674 | Hypophosphatemia | DISEASE | ci_with | calcium glycerophosphate |
| MEDRT | D007669 | Kidney Calculi | DISEASE | ci_with | calcium glycerophosphate |
| MEDRT | D015663 | Osteoporosis, Postmenopausal | DISEASE | may_treat | calcium glycerophosphate |
| MEDRT | D012640 | Seizures | DISEASE | may_treat | pyridoxine |
| MEDRT | D012640 | Seizures | DISEASE | may_treat | pyridoxine hydrochloride |
| MEDRT | D026681 | Vitamin B 6 Deficiency | DISEASE | may_prevent | pyridoxine |
| MEDRT | D026681 | Vitamin B 6 Deficiency | DISEASE | may_treat | pyridoxine |
| MEDRT | D026681 | Vitamin B 6 Deficiency | DISEASE | may_prevent | pyridoxine hydrochloride |
| MEDRT | D026681 | Vitamin B 6 Deficiency | DISEASE | may_treat | pyridoxine hydrochloride |
| MEDRT | N0000000220 | Electrolyte Activity | MOA | has_moa | calcium glycerophosphate |
| MEDRT | N0000000163 | Enzyme Interactions | MOA | has_moa | pyridoxine hydrochloride |
| MEDRT | N0000000163 | Enzyme Interactions | MOA | has_moa | pyridoxine |
| MEDRT | N0000008312 | Bone Resorption Alteration | PE | has_pe | calcium glycerophosphate |
| MEDRT | N0000008337 | Cellular Activity Alteration | PE | has_pe | pyridoxine |
| MEDRT | N0000008337 | Cellular Activity Alteration | PE | has_pe | pyridoxine hydrochloride |
| MEDRT | N0000009557 | Increased Renal PO4-- Excretion | PE | has_pe | calcium glycerophosphate |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | GENERAL_CARDINALITY | MULTI |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |